Concepedia
Statistics
Publications
12
Citations
602
H-Index
Active since
1988
Affiliations
Abbott Fund(Current)
Abbott (United Kingdom)
Discovery Laboratories (United States)
Abbott (United States)
Lisa Bednarz is an author at Abbott Fund specializing in pharmacology, neuropharmacology, and medicine.
Publications per year
1988–1996
Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
Francis J. White, Lisa Bednarz, Stephen R. Wachtel et al. · Pharmacology Biochemistry and Behavior · 1988 · 178 citations
Life Sciences, Neurobiology, Neuroscience +14
A68930: a potent agonist selective for the dopamine D1 receptor
Michael P. DeNinno, Robert Schoenleber, Robert G. MacKenzie et al. · European Journal of Pharmacology · 1991 · 88 citations
Medicine, Medicinal Chemistry, Pharmacology +14
Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.
Karen E. Asin, Lisa Bednarz, Arthur L. Nikkel et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 46 citations
Medicine, Neuroscience, Pharmacology +16
Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
Chii‐Wann Lin, Benedetta Bianchi, T. R. Miller et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 46 citations
Medicine, Neuroscience, Pharmacology +17
Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats
Karen E. Asin, P.A. Gore, Lisa Bednarz et al. · Brain Research · 1992 · 44 citations
Medicine, Endocrinology, Pharmacology +11
1–5 of 12